Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Physical Review Letters|April 26, 2018
Laser Cooled YbF Molecules for Measuring the Electron's Electric Dipole MomentJ Lim, J R Almond, M A Trigatzis, et al.Medical Physics|September 1, 1986
Clarification of the AAPM Task Group 21 protocolR J Schulz, P R Almond, G Kutcher, et al.Medical Physics|January 1, 1977
Composition of A-150 tissue-equivalent plasticJ B Smathers, V A Otte, A R Smith, et al.Medical Physics|August 13, 2004
Dose properties of a laser accelerated electron beam and prospects for clinical applicationK K Kainz, K R Hogstrom, J A Antolak, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 1993
Molecular basis for the inhibition of human alpha-thrombin by the macrocyclic peptide cyclotheonamide AB E Maryanoff, X Qiu, K P Padmanabhan, et al.Biochemical Pharmacology|December 14, 1993
Varicella-zoster virus thymidine kinase. Characterization and substrate specificityG B Roberts, J A Fyfe, S A McKee, et al.Journal of Medicinal Chemistry|May 23, 1997
Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agentsJ R Carson, R J Carmosin, P M Pitis, et al.Antimicrobial Agents and Chemotherapy|May 5, 2010
Development of hexadecyloxypropyl tenofovir (CMX157) for treatment of infection caused by wild-type and nucleoside/nucleotide-resistant HIVE Randall Lanier, Roger G Ptak, Bernhard M Lampert, et al.Antimicrobial Agents and Chemotherapy|July 25, 2007
Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infectionsGeorge R Painter, Merrick R Almond, Lawrence C Trost, et al.Bioorganic & Medicinal Chemistry Letters|June 24, 2000
Novel inhibitors of HIV protease: design, synthesis and biological evaluation of picomolar inhibitors containing cyclic P1/P2 scaffoldsA Spaltenstein, M R Almond, W J Bock, et al.Pageof 9